Third Harmonic Bio To Liquidate, To Distribute Up To $255.4 Mln To Shareholders; Stock Climbs
https://www.rttnews.com/story.aspx?Id=3528499
Apr 14, 2025 - Shares of Third Harmonic Bio, Inc. (THRD) were surging around 38 percent in the pre-market activity on the Nasdaq, after the clinical-stage biopharmaceutical company announced Monday that its board of directors has approved a plan to liquidate and dissolute the firm and to distribute remaining cash to stockholders following an orderly wind down of the company's operations.
0
GRI Bio Announces Positive Safety Data Of GRI-0621, Stock Soars In Pre-Market
https://www.rttnews.com/story.aspx?Id=3525973
Apr 01, 2025 - GRI Bio, Inc. (GRI), Tuesday announced encouraging interim safety results from its ongoing Phase 2a study, evaluating GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis.
0
TELA Bio Launches Larger Sizes Of OviTex PRS Reinforced Tissue Matrix In US
https://www.rttnews.com/story.aspx?Id=3525576
Mar 31, 2025 - TELA Bio, Inc. (TELA), Monday announced the launch of larger sizes of OviTex PRS Reinforced Tissue Matrix in the U.S., specifically engineered for plastic and reconstructive surgery.
0
Key deals this week: xAI acquires X; bluebird bio, Nvidia, Dollar Tree and more
https://seekingalpha.com/news/4426686-key-deals-this-week-xai-acquires-x-bluebird-bio-nvidia-dollar-tree-and-more?source=feed_sector_healthcare
Mar 29, 2025 -
0
bluebird bio sees higher offer for company from Ayrmid Pharma
https://seekingalpha.com/news/4426667-bluebird-bio-sees-higher-offer-company-ayrmid-pharma?source=feed_sector_healthcare
Mar 28, 2025 -
0
Entera Bio GAAP EPS of -$0.25 beats by $0.03, revenue of $0.18M beats by $0.04M
https://seekingalpha.com/news/4426625-entera-bio-gaap-eps-of-0_25-beats-by-0_03-revenue-of-0_18m-beats-by-0_04m?source=feed_tag_israel
Mar 28, 2025 -
0
Annovis Bio receives NYSE notice over non-compliance with listing rules
https://seekingalpha.com/news/4426071-annovis-bio-receives-nyse-notice-over-non-compliance-with-listing-rules?source=feed_sector_healthcare
Mar 27, 2025 -
0
Tela Bio slumps after Q4 miss as Piper Sandler downgrades
https://seekingalpha.com/news/4423578-tela-bio-stock-falls-piper-downgrades-q4-miss?source=feed_sector_healthcare
Mar 21, 2025 -
0
TELA Bio, Inc. 2024 Q4 - Results - Earnings Call Presentation
https://seekingalpha.com/article/4769324-tela-bio-inc-2024-q4-results-earnings-call-presentation?source=feed_all_articles
Mar 20, 2025 -
0
TELA Bio sees 23-27% revenue growth for 2025 with expanded sales strategy
https://seekingalpha.com/news/4423237-tela-bio-sees-23minus-27-percent-revenue-growth-for-2025-with-expanded-sales-strategy?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Mar 20, 2025 -
0